Industry approaches to automation of cell-based bioassay
Broadcast date
Wed, Oct 27, 2021
Presented by
- John White - GSKÁsdís Olsen Pétursdóttir - Novo NordiskDenny Dimitrov - GSKAndrew Thomson - GSKDan Schuessler - GSKTianyi Zhang - GSKShawn Gauby - GSK
Quick Description
Well Characterized Biologics and Biological Assays – virtual conference 2021
BioPhorum Session: industry approaches to automation of cell-based bioassays
Details
BioPhorum’s Development Group Bioassay workstream consists of 34 global companies from the biopharmaceutical industry. Representatives from the workstream presented the results of discussions and a benchmarking survey on the automation of cell-based potency assays.
The talk focused on a number of topics including; handling of cells, transitioning from manual to automated assays and validation approaches when assays are both manual and automated.
Speakers
John White
Director BioPharm Assay Development
GSK
Ásdís Olsen Pétursdóttir
Research Scientist
Novo Nordisk
Denny Dimitrov
Bioassay Development and Automation
GSK
Andrew Thomson
Biopharm R & D Technician
GSK
Dan Schuessler
Analytical Automation Leader
GSK
Tianyi Zhang
Analytical Automation Specialist
GSK
Shawn Gauby
Investigator - IVIV Translation
GSK